OptiMedica’s Catalys Precision Laser System demonstrates unprecedented performance in cataract surgery, according to a clinical data presentation delivered at ESCRS 2012 held from September 8 to 12, 2012, in Milan.
Catalys was the topic of several presentations delivered at the meeting, where Prof. Burkhard Dick, Chairman and Head of the University Eye Clinic Bochum, Germany, presented his experience with Catalys under the title ‘Femtosecond cataract surgery outcomes: an advance or not?.’ After successfully completing over 850 surgeries in his clinic, Prof. Dick confirmed that laser cataract surgery using Catalys is a significant advancement when compared to manual surgery.
Prof. Dick became the first physician in Europe to employ Catalys for corneal incisions, an indication which received CE mark approval in March 2012 and market clearance from the U.S. Food and Drug Administration in August 2012.
At ESCRS, information garnered by Prof. Dick on corneal arcuate incisions was presented by Dr. William W. Culbertson from the Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami. Findings of the 14-patient study confirmed that Catalys performed these incisions with unprecedented precision in geometry, placement and size, with optical zone accuracy within 0.83% of intended and length and axis accuracy within 0.22 degrees of intended.
Prof. Dick informed that Catalys is an innovative product that has enhanced his ability to perform cataract surgery on a large number of cataract patients. The system’s accuracy and results are unprecedented in the field and its novel capabilities have laid the foundation of his cataract practice.
Dr. Culbertson expects that Catalys will transform the level of care in cataract surgery, thanks to its several key advantages for patients and surgeons.